Cerba HealthCare’s mission is to support the evolution from a curative health system towards a more preventive system.
Every day, clinical pathology helps us take care of our health by providing data that enlightens the clinician's medical diagnosis and prescription.
Since 1967, we have been innovating to support scientific and technological progress in the service of diagnosis, prevention and precision medicine for all.
Alongside associations and its public and institutional partners, the Cerba Institute is mobilizing to support patients, health professionals and research teams.
Samuel joined the Board of Cerba HealthCare in 2022.
He is Director in the investment team Bpifrance Large Cap, with fifteen years of experience in finance and private equity. Samuel is also Director at the Boards of Eutelsat, Soitec, and Crouzet, as well as financial controller at the Board of STMicroelectronics.
Samuel Dalens graduated from École Polytechnique and from Telecom Paris.